Skip to content

Japt.gr

Hellenic Atherosclerosis Society
  • HOME
  • ABOUT
    • SCOPE
    • EDITORIAL BOARD
  • CURRENT ISSUE
  • ARCHIVES
    • VOLUME 13 (2022)
      • Volume 13 – Issue 1
    • VOLUME 12 (2021)
      • Volume 12 – Issue 1
      • Volume 12 – Issue 2
      • Volume 12 – Issue 3
      • Volume 12 – Suppl. 1
    • VOLUME 11 (2020)
      • Volume 11 – Issue 1
      • Volume 11 – Issue 2
      • Volume 11 – Issue 3
      • Volume 11 – Suppl. 1
    • VOLUME 10 (2019)
      • Volume 10 – Issue 1
      • Volume 10 – Suppl. 1
    • VOLUME 9 (2018)
      • Volume 9 – Issue 1
      • Volume 9 – Issue 2
      • Volume 9 – Issue 3
      • Volume 9 – Issue 4
    • VOLUME 8 (2017)
      • Volume 8 – Issue 1
      • Volume 8 – Issue 2
      • Volume 8 – Issue 3
      • Volume 8 – Issue 4
    • VOLUME 7 (2016)
      • Volume 7 – Issue 1
      • Volume 7 – Issue 2
      • Volume 7 – Issue 3
      • Volume 7 – Issue 4
    • VOLUME 6 (2015)
      • Volume 6 – Issue 1
      • Volume 6 – Issue 2
      • Volume 6 – Issue 3
      • Volume 6 – Issue 4
    • VOLUME 5 (2014)
      • Volume 5 – Issue 1
      • Volume 5 – Issue 2
      • Volume 5 – Issue 3
    • VOLUME 4 (2013)
      • Volume 4 – Issue 1
      • Volume 4 – Issue 2
      • Volume 4 – Issue 3
    • VOLUME 3 (2012)
      • Volume 3 – Issue 3
  • FOR AUTHORS
  • SUBMIT MANUSCRIPT
  • CONTACT
  • Menu

Tag Archives: atorvastatin

The effects of atorvastatin 30 mg compared with atorvastatin 40 mg in patients with primary hyperlipidemia: a multicenter study

Christos Rizos, Evangelos Liberopoulos, Eleni Mpilianou, Vasileios Kotsis, Nikolaos Tentolouris, Christina Antza, Ioanna Eleftheriadou, Vasileios Tsimihodimos, Moses Elisaf

Effect of nebivolol or nebivolol/hydrochlorothiazide plus atorvastatin on glycemic profile in patients with hypertension and dyslipidemia

Elisavet Moutzouri, Anastazia Kei, Evangelos Liberopoulos, Moses Elisaf

CURRENT ISSUE

Dietary Patterns and Cardiovascular Disease: A systematic review of 29 prospective studies with 1,249,644 participants, published in the last 20 years
Nonalcoholic fatty liver disease
Social support in predicting CVD patients’ quality of life
Antidiabetic drugs in patients with Covid-19 infection

Keywords

acute coronary syndrome (4) arterial stiffness (5) Atherosclerosis (19) blood pressure (3) cardiovascular disease (21) cardiovascular diseases (6) cardiovascular events (3) Cardiovascular risk (4) coronary artery disease (4) coronary heart disease (4) COVID-19 (4) diabetes (3) diabetes mellitus (9) diet (3) dyslipidemia (14) ezetimibe (4) Familial hypercholesterolemia (4) Heart failure (5) hypertension (7) inflammation (9) Ischemic stroke (3) lipoproteins (4) longevity (3) Mediterranean diet (7) metabolic syndrome (7) morbidity (3) mortality (7) NAFLD (3) non-alcoholic fatty-liver disease (4) obesity (7) omega-3 fatty acids (3) outcome (3) PCSK9 inhibitors (4) physical activity (3) platelets (8) primary prevention (3) pulse wave velocity (3) rosuvastatin (3) smoking (3) statins (14) stroke (3) thrombin (3) thrombosis (4) treatment (5) type 2 diabetes mellitus (4)
Journal of Atherosclerosis Prevention and Treatment    ©2022
A SiteOrigin Theme